AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33172941 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous desmopressin
Number of subjects: 50
Study 35838997 — intervention group
Group type: EXPERIMENTAL
Intervention: CDM group
Number of subjects: 0
Study 35838997 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34321539 — intervention group
Group type: EXPERIMENTAL
Intervention: Denneroll cervical traction
Number of subjects: 80
Study 34321539 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 80
Study 32217783 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy conservation technique (ECT)
Number of subjects: 22
Study 32217783 — intervention group
Group type: COMPARATOR
Intervention: Control condition (climbing stairs at own pace)
Number of subjects: 22
Study 35262556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth bleaching treatment
Number of subjects: 79
Study 35262556 — intervention group
Group type: EXPERIMENTAL
Intervention: OHIP‐Aes‐Braz
Number of subjects: 79
Study 35262556 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with tooth color satisfaction and self‐perceived oral health
Number of subjects: 79
Study 33074282 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-calorie refeeding, beginning at 2000 kcal/d and increasing by 200 kcal/d
Number of subjects: 120
Study 33074282 — intervention group
Group type: COMPARATOR
Intervention: Lower-calorie refeeding, beginning at 1400 kcal and increasing by 200 kcal every other day
Number of subjects: 120
Study 33074282 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-calorie refeeding
Number of subjects: 120
Study 33106874 — intervention group
Group type: EXPERIMENTAL
Intervention: Order recommender system
Number of subjects: 43
Study 35864625 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) - 25 mg/kg bolus followed by 1 mg/kg/hour infusion
Number of subjects: 50
Study 35864625 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 50
Study 35003484 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence Boost only
Number of subjects: 68
Study 35003484 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence Boost plus Er:YAG laser
Number of subjects: 68
Study 35003484 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence Boost plus Nd:YAG laser
Number of subjects: 68
Study 35003484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study 36263691 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine therapy (AT) with cognitive behavior therapy (CBT)
Number of subjects: 60
Study 36263691 — intervention group
Group type: COMPARATOR
Intervention: Agomelatine therapy (AT) without cognitive behavior therapy (CBT)
Number of subjects: 60
Study 34301748 — intervention group
Group type: EXPERIMENTAL
Intervention: osimertinib
Number of subjects: 682
Study 34301748 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 682
Study 32516270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline smoking
Number of subjects: 34
Study 32516270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline drinking
Number of subjects: 34
Study 32516270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline alcohol craving
Number of subjects: 34
Study 32516270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline tobacco craving
Number of subjects: 34
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 5866
Study 33812977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 5866
Study 33812977 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 5866
Study 33812977 — intervention group
Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 5866
Study 33198760 — intervention group
Group type: EXPERIMENTAL
Intervention: PM2.5 exposure (mean: 37.8 μg/m3, SD 6.5)
Number of subjects: 20
Study 33198760 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (mean: 2.1 μg/m3, SD 2.6)
Number of subjects: 20
Study 33190607 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal drawing-in maneuver (ADIM) technique for 1 minute, repeated three times during 41 minutes of sitting.
Number of subjects: 24
Study 33190607 — intervention group
Group type: COMPARATOR
Intervention: Control condition (sitting without ADIM technique).
Number of subjects: 24
Study 32096346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 509
Study 32096346 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for recurrence-free survival (RFS)
Number of subjects: 509
Study 32096346 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves
Number of subjects: 509
Study 32096346 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaplan-Meier curves and Decision Curve Analysis (DCA)
Number of subjects: 509
Study 35473570 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Subthreshold Exercise Program (MSTEP)
Number of subjects: 200
Study 35473570 — intervention group
Group type: COMPARATOR
Intervention: Stretching condition (control)
Number of subjects: 200
Study 34304826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) for 6 months, 30 min, 3 times per week, 10-30 s bouts at >90% age-predicted maximum heart rate with equal rest
Number of subjects: 616
Study 34304826 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 616
Study 32199333 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐term born adults
Number of subjects: 37
Study 32199333 — intervention group
Group type: COMPARATOR
Intervention: Full‐term born controls
Number of subjects: 37
Study 32199333 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (normoxia and hypoxia)
Number of subjects: 37
Study 35583606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold events (temperature below freezing)
Number of subjects: 0
Study 35583606 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm events (minimum temperature > 10 °C)
Number of subjects: 0
Study 35583606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold waves
Number of subjects: 0
Study 35583606 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat waves
Number of subjects: 0
Study 34689453 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete cervical third protection with gingival dam
Number of subjects: 35
Study 34689453 — intervention group
Group type: COMPARATOR
Intervention: Traditional gingival barrier application
Number of subjects: 35
Study 34552200 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 300
Study 34552200 — intervention group
Group type: COMPARATOR
Intervention: 200 mg DHA/day
Number of subjects: 300
Study 32570710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugarcane flour (3 g per day)
Number of subjects: 43
Study 32570710 — intervention group
Group type: COMPARATOR
Intervention: Cellulose placebo (3 g per day)
Number of subjects: 43
Study 35556174 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill and nanoparticulate composite resins (ABF)
Number of subjects: 53
Study 35556174 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill and microhybrid composite resins (XST)
Number of subjects: 53
Study 35556174 — intervention group
Group type: COMPARATOR
Intervention: Conventional microhybrid composite resin (PA)
Number of subjects: 53
Study 35096107 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinpi Tongfeng Formula (QPTFF) combined with bloodletting therapy
Number of subjects: 86
Study 35096107 — intervention group
Group type: COMPARATOR
Intervention: Colchicine tablets
Number of subjects: 86
Study 32663912 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 25 μg
Number of subjects: 45
Study 32663912 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 100 μg
Number of subjects: 45
Study 32663912 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 250 μg
Number of subjects: 45
Study 32663912 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Number of subjects: 45
Study 616775744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaco-invasive (PI)
Number of subjects: 143
Study 616775744 — intervention group
Group type: COMPARATOR
Intervention: Primary PCI (PPCI)
Number of subjects: 143
Study 616775744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PI and PPCI
Number of subjects: 143
Study 34560797 — intervention group
Group type: EXPERIMENTAL
Intervention: MAKS intervention (Motor, Activities of daily living, Cognitive and Social-communicative component) implemented in DCC
Number of subjects: 287
Study 34560797 — intervention group
Group type: COMPARATOR
Intervention: No MAKS intervention in DCC
Number of subjects: 287
Study 34622665 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 5845
Study 34622665 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 5845
Study 34622665 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of statin therapy and vorapaxar
Number of subjects: 5845
Study 32814661 — intervention group
Group type: COMPARATOR
Intervention: 5 mg/ml fibrinogen and 25 U/ml thrombin (physiological as a control)
Number of subjects: 48
Study 32814661 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/ml fibrinogen and 250 U/ml thrombin (low adhesive)
Number of subjects: 48
Study 32814661 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/ml fibrinogen and 250 U/ml thrombin (high adhesive)
Number of subjects: 48
Study 35387238 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg twice a day before chemotherapy
Number of subjects: 60
Study 35387238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32798159 — intervention group
Group type: EXPERIMENTAL
Intervention: Erich arch bars (EABs)
Number of subjects: 15
Study 35396305 — intervention group
Group type: EXPERIMENTAL
Intervention: PTI (Intervention for patients)
Number of subjects: 2334
Study 35396305 — intervention group
Group type: COMPARATOR
Intervention: UC (Usual Care)
Number of subjects: 2334
Study 35396305 — intervention group
Group type: EXPERIMENTAL
Intervention: PFI (Intervention for primary care professionals)
Number of subjects: 2334
Study 35396305 — intervention group
Group type: EXPERIMENTAL
Intervention: CBI (Combined intervention for patients and professionals)
Number of subjects: 2334
Study 33965944 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial coil treatment
Number of subjects: 120
Study 33965944 — intervention group
Group type: COMPARATOR
Intervention: Control (Standard-of-Care Medical Management)
Number of subjects: 120
Study 35708691 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 (screening mammogram result letter with breast density messaging and existing density information letter)
Number of subjects: 1420
Study 35708691 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2 (screening mammogram result letter with breast density messaging and health literacy-sensitive version)
Number of subjects: 1420
Study 35708691 — intervention group
Group type: COMPARATOR
Intervention: Control (screening mammogram result letter without breast density messaging)
Number of subjects: 1420
Study 33549554 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 4744
Study 33549554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 34715162 — intervention group
Group type: EXPERIMENTAL
Intervention: piTBS
Number of subjects: 75
Study 34715162 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-rTMS
Number of subjects: 75
Study 34715162 — intervention group
Group type: COMPARATOR
Intervention: sham
Number of subjects: 75
Study 34666678 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimisation intervention for personal continuity of care
Number of subjects: 0
Study 35123203 — intervention group
Group type: EXPERIMENTAL
Intervention: Online multi-domain cognitive training (CT), 24 sessions over 8 weeks
Number of subjects: 71
Study 35123203 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 71
Study 35123203 — intervention group
Group type: EXPERIMENTAL
Intervention: Online multi-domain cognitive training (CT)
Number of subjects: 71
Study 32882244 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 1641
Study 32882244 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 1641
Study 35109526 — intervention group
Group type: EXPERIMENTAL
Intervention: Doll therapy (DT)
Number of subjects: 129
Study 35109526 — intervention group
Group type: COMPARATOR
Intervention: Active control (cube)
Number of subjects: 129
Study 32194222 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (2,700 mg/day)
Number of subjects: 60
Study 32194222 — intervention group
Group type: COMPARATOR
Intervention: Placebo (900 mg of edible paraffin)
Number of subjects: 60
Study 36042488 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% tetrasodium EDTA (KiteLock Sterile Locking Solution™)
Number of subjects: 0
Study 36042488 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (normal saline as a catheter locking solution)
Number of subjects: 0
Study 34938828 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer delivered brief alcohol intervention (CBI)
Number of subjects: 439
Study 34938828 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer delivered brief alcohol intervention with interactive voice response counseling and text messages (CBI‐IVR‐TM)
Number of subjects: 439
Study 34938828 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 439
Study 34938828 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CBI, CBI‐IVR‐TM, Attention control)
Number of subjects: 439
Study 33891333 — intervention group
Group type: EXPERIMENTAL
Intervention: HTL0009936 (IV)
Number of subjects: 0
Study 33891333 — intervention group
Group type: COMPARATOR
Intervention: Physostigmine
Number of subjects: 0
Study 32353277 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (3-5 months) followed by management as usual
Number of subjects: 684
Study 32353277 — intervention group
Group type: COMPARATOR
Intervention: Management as usual
Number of subjects: 684
Study 33931067 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL repair using cortical button fixation and additional suture augmentation
Number of subjects: 74
Study 33931067 — intervention group
Group type: COMPARATOR
Intervention: ACL reconstruction using an all‐inside autologous hamstring graft technique
Number of subjects: 74
Study 33931067 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL repair
Number of subjects: 74
Study 34070161 — intervention group
Group type: EXPERIMENTAL
Intervention: Inquiry Based Stress Reduction (IBSR)
Number of subjects: 56
Study 34070161 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study 33242443 — intervention group
Group type: EXPERIMENTAL
Intervention: VTD (bortezomib, thalidomide, and dexamethasone)
Number of subjects: 480
Study 33242443 — intervention group
Group type: COMPARATOR
Intervention: TD (thalidomide and dexamethasone)
Number of subjects: 480
Study 35451359 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver meat balls (LMB) supplement 3 times a week for 90 days
Number of subjects: 60
Study 34748565 — intervention group
Group type: EXPERIMENTAL
Intervention: zoledronate (5mg)
Number of subjects: 43
Study 34748565 — intervention group
Group type: EXPERIMENTAL
Intervention: methylprednisolone (1gm)
Number of subjects: 43
Study 34748565 — intervention group
Group type: COMPARATOR
Intervention: placebo (100ml normal saline)
Number of subjects: 43
Study 34748565 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study 33919205 — intervention group
Group type: COMPARATOR
Intervention: Kinesiology taping (KT) with paper-off tension
Number of subjects: 12
Study 33919205 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) with 50% tension
Number of subjects: 12
Study 32359057 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol labels with national drinking guidelines, a cancer warning, and standard drink information applied to alcohol containers.
Number of subjects: 2049
Study 35302300 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 200
Study 35302300 — intervention group
Group type: COMPARATOR
Intervention: Granisetron
Number of subjects: 200
Study 32764474 — intervention group
Group type: EXPERIMENTAL
Intervention: VERTICAL with online teacher training
Number of subjects: 1639
Study 32764474 — intervention group
Group type: EXPERIMENTAL
Intervention: VERTICAL with additional face-to-face teacher training
Number of subjects: 1639
Study 32764474 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1639
Study 32764474 — intervention group
Group type: EXPERIMENTAL
Intervention: VERTICAL
Number of subjects: 1639
Study 36446724 — intervention group
Group type: EXPERIMENTAL
Intervention: KangDuo surgical robot (KD‐SR)
Number of subjects: 100
Study 36446724 — intervention group
Group type: COMPARATOR
Intervention: da Vinci Si Surgical System (DV‐SS‐Si)
Number of subjects: 100
Study 33540298 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure applied for a total of 12 minutes (3 minutes at each of the ST25, CV12, TH6, and HT7 acupuncture points) at 0, 4, and 8 hours postoperatively
Number of subjects: 0
Study 33540298 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity modulated and image guided radiation therapy (RT) with a dose of 50.4 Gy to primary PTV and 42 Gy to lymph node PTV, delivered over 28 fractions, with chemotherapy.
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of vaginal dilators during RT to maximize genitalia sparing.
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized immobilization device and daily image guided RT.
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous integrated boost technique with a 10‐mm margin on the gross tumor plus anal complex for primary clinical target volume.
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: 7‐mm expansion on blood vessels for elective lymph node clinical target volume.
Number of subjects: 0
Study 35717050 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐ to 10‐mm planning target volume (PTV) margin based on institutional setup and patient‐specific factors.
Number of subjects: 0
Study 34979824 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression Point Displacement (RPD) design
Number of subjects: 0
Study 34979824 — intervention group
Group type: COMPARATOR
Intervention: Control groups from the RCTs
Number of subjects: 0
Study 36097638 — intervention group
Group type: EXPERIMENTAL
Intervention: Rad-score
Number of subjects: 179
Study 36097638 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 179
Study 36097638 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive lymph nodes
Number of subjects: 179
Study 36097638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer antigen-125
Number of subjects: 179
Study 33888981 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application (app) group
Number of subjects: 77
Study 33888981 — intervention group
Group type: COMPARATOR
Intervention: Booklet group
Number of subjects: 77
Study 32711555 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 196
Study 32711555 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 196
Study 34407023 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Mindfulness-Based Stress Reduction (MBSR) program for 7 weeks
Number of subjects: 0
Study 34407023 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 34407023 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 0
Study 32804885 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion to the touched vertebra (TV)
Number of subjects: 299
Study 32804885 — intervention group
Group type: COMPARATOR
Intervention: Fusion cephalad to the TV
Number of subjects: 299
Study 32804885 — intervention group
Group type: COMPARATOR
Intervention: Fusion caudad to the TV
Number of subjects: 299
Study 32804885 — intervention group
Group type: COMPARATOR
Intervention: Fusion with lumbar modifier 'A'
Number of subjects: 299
Study 32804885 — intervention group
Group type: COMPARATOR
Intervention: Fusion with lumbar modifiers 'B' and 'C'
Number of subjects: 299
Study 35439906 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 117
Study 35439906 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 117
Study 34104089 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment
Number of subjects: 30
Study 34104089 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-BPD infants)
Number of subjects: 30
Study 32920824 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroid (TCS)
Number of subjects: 517
Study 32920824 — intervention group
Group type: COMPARATOR
Intervention: Handheld narrowband ultraviolet B (NB-UVB)
Number of subjects: 517
Study 32920824 — intervention group
Group type: COMPARATOR
Intervention: Combination of topical corticosteroid (TCS) and NB-UVB
Number of subjects: 517
Study 33347643 — intervention group
Group type: EXPERIMENTAL
Intervention: Local optimization algorithm for Kohn-Sham equations
Number of subjects: 0
Study 33347643 — intervention group
Group type: EXPERIMENTAL
Intervention: Local optimization algorithm with randomization of initial approximation
Number of subjects: 0